CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-03-07 | Alvino Mark Director | Grant or award · Stock option (right to buy) | +125,000 | $0.37 | $46K | 231,000 |
| 2014-03-07 | Alvino Mark Director | Grant or award · Stock option (right to buy) | +375,000 | $0.37 | $139K | 606,000 |
| 2014-03-07 | Jeffrey B Davis CEO | Grant or award · Stock option (right to buy) | +500,000 | $0.37 | $185K | 525,000 |
| 2014-03-07 | Jeffrey B Davis CEO | Grant or award · Stock option (right to buy) | +1,500,000 | $0.37 | $555K | 2,025,000 |
| 2014-03-07 | Rouhandeh Steven H Director | Grant or award · Stock option (right to buy) | +1,000,000 | $0.37 | $370K | 1,000,000 |
| 2014-03-07 | Rouhandeh Steven H Director | Grant or award · Stock option (right to buy) | +3,000,000 | $0.37 | $1.1M | 4,000,000 |
| 2012-12-19 | SCO CAPITAL PARTNERS LLC 10% owner | Gift · Series B Cumulative Convertible Preferred Stock | −68.31 | $10,000.00 | $683K | 861.39 |
| 2012-12-19 | SCO CAPITAL PARTNERS LLC 10% owner | Gift · Series B Cumulative Convertible Preferred Stock | +68.31 | $10,000.00 | $683K | 138.61 |
| 2012-12-19 | SCO CAPITAL PARTNERS LLC 10% owner | Gift · Common Stock Purchase Warrants | −1,366,202 | 17,227,798 | ||
| 2012-12-19 | SCO CAPITAL PARTNERS LLC 10% owner | Gift · Common Stock Purchase Warrants | +1,366,202 | 2,772,202 | ||
| 2012-12-11 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2012-10-25 | SCO CAPITAL PARTNERS LLC 10% owner | Purchase · Series B Cumulative Convertible Preferred Stock | +929.7 | $10,000.00 | $9.3M | 929.7 |
| 2012-10-25 | SCO CAPITAL PARTNERS LLC 10% owner | Purchase · Series B Cumulative Convertible Preferred Stock | +70.3 | $10,000.00 | $703K | 70.3 |
| 2012-10-25 | SCO CAPITAL PARTNERS LLC 10% owner | Purchase · Common Stock Purchase Warrants | +18,594,000 | 18,594,000 | ||
| 2012-10-25 | SCO CAPITAL PARTNERS LLC 10% owner | Purchase · Common Stock Purchase Warrants | +1,406,000 | 1,406,000 | ||
| 2012-06-29 | Ayer Capital Management, LP 10% owner | Sale | −179,157 | $0.55 | $99K | 2,413,163 |
| 2012-06-28 | Ayer Capital Management, LP 10% owner | Sale | −25,000 | $0.68 | $17K | 2,592,320 |
| 2012-05-24 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +700 | 700 | ||
| 2012-05-24 | THOMPSON STEPHEN B CFO | Grant or award · Stock option (right to buy) | +50,000 | $0.61 | $31K | 443,000 |
| 2012-05-24 | NOWOTNIK DAVID P Sr. VP R&D | Grant or award · Stock option (right to buy) | +50,000 | $0.61 | $31K | 555,000 |
Page 25 of 34 · 664 trades